Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic
Objective was to investigate the SARS-CoV-2 collective immunity status of the population of Belarus within the context of the COVID-19 pandemic. Materials and methods. The work was carried out according to the methodology for assessing SARS-CoV-2 population immunity, developed by Rospotrebnadzor Rus...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | RU |
| Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/7a20d2a50a0d40778c1500b10a0c6507 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:7a20d2a50a0d40778c1500b10a0c6507 |
|---|---|
| record_format |
dspace |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
RU |
| topic |
coronaviruses sars-cov-2 covid-19 morbidity seroprevalence asymptomatic course republic of belarus population vaccination anti-nucleocapsid antibodies anti-rbd antibodies gam-covid-vac vaccine (sputnik v) bbibp-corv vaccine Infectious and parasitic diseases RC109-216 |
| spellingShingle |
coronaviruses sars-cov-2 covid-19 morbidity seroprevalence asymptomatic course republic of belarus population vaccination anti-nucleocapsid antibodies anti-rbd antibodies gam-covid-vac vaccine (sputnik v) bbibp-corv vaccine Infectious and parasitic diseases RC109-216 A. Yu. Popova A. A. Tarasenko V. Yu. Smolensky S. A. Egorova V. S. Smirnov A. M. Dashkevich T. N. Svetogor I. N. Glinskaya A. L. Skuranovich A. M. Milichkina A. M. Dronina E. O. Samoilovich I. V. Khamitova G. V. Semeiko T. V. Amvrosyeva N. P. Shmeleva L. V. Rubanik O. P. Esmanchik I. A. Karaban V. G. Drobyshevskaya G. V. Sadovnikova M. V. Shilovich E. A. Podushkina V. V. Kireichuk O. A. Petrova S. V. Bondarenko I. F. Salazhkova L. M. Tkach L. P. Shepelevich N. L. Autukhova V. M. Ivanov A. S. Babilo M. V. Navyshnaya N. N. Belyaev E. V. Zueva L. A. Volosar V. N. Verbov I. V. Likhachev T. O. Zagorskaya N. F. Morozova Z. R. Korobova A. V. Gubanova A. A. Totolian Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic |
| description |
Objective was to investigate the SARS-CoV-2 collective immunity status of the population of Belarus within the context of the COVID-19 pandemic. Materials and methods. The work was carried out according to the methodology for assessing SARS-CoV-2 population immunity, developed by Rospotrebnadzor Russia and the Ministry of Health of Belarus with the participation of the St. Petersburg Pasteur Institute, taking into account WHO recommendations. The Bioethics Committee of Belarus and the local ethics committee of the St. Petersburg Pasteur Institute approved the study. Selection of participants was carried out using a questionnaire method and online technology (internet, cloud server). Volunteers were randomized into seven age groups (years of age): 1–17; 18–29; 30–39; 40–49; 50–59; 60–69; and 70+. Regional randomization ensured proportional representation of volunteers from each region, and no more than 30 people were included from one enterprise. In accordance with manufacturer instructions, blood plasma samples were analyzed for: IgG antibodies (Abs) to the SARS-CoV-2 nucleocapsid (Nc) using a quantitative ELISA test system; and IgG Abs to the receptor binding domain (RBD) of the SARS-CoV-2 S (spike) surface glycoprotein using a qualitative ELISA test system. Statistical processing was carried out using Excel 2010 and other software. Statistical differences were designated as significant when p < 0.05, unless otherwise indicated. Results. The level of seroprevalence, in terms of Abs to Nc among the Belarusian population, was 38.4% (95% CI 37.6–45.4). The highest Ab levels were found among individuals in older age groups (50-70+ years old). The lowest were found in children 1–17 years old and in young people 18–39 years old The distribution of seroprevalence across Belarusian regions was relatively homogeneous, with the exception of the Minsk Region, where a statistically significant decrease in the indicator was noted. In terms of profession, the largest share of seropositive individuals was found among transportation workers; the smallest was found in business. The moderate COVID-19 incidence has not led to a dramatic increase in the number of contacts. The base reproduction number (R0) was 1.3. In the Republic of Belarus, there was a moderate level of asymptomatic COVID-19 among seropositive individuals (45.3% [95% CI 44.0–46.7]). This form of infection was observed most often among children aged 1–17 years old (65.0% [95% CI 61.3–68.6]). In parallel with seroprevalence assessment, SARS-CoV-2 vaccination was carried out. We used two vaccines: Gam-COVID-Vac (also known as Sputnik V, developed by Gamaleya National Center for Epidemiology and Microbiology, Russia); and BBIBP-CorV (Sinopharm, PRC). Vaccination against SARS-CoV-2 was accompanied by an increase in the level of anti-RBD Abs (95% [95% CI 94.7–96.7]). Taking into account the vaccination of a subset of the population with BBIBP-CorV, the overall herd immunity, inferred from the analyzed indicators (presence of anti-Nc or anti-RBD Abs), was 47.1% (95% CI 46.3–48.0). Conclusion. COVID-19 in Belarus was characterized by a moderately pronounced course of the epidemic process. The threshold level of herd immunity to SARS-CoV-2 has not yet been reached, as a result of which the conditions for progression of the epidemic remain. |
| format |
article |
| author |
A. Yu. Popova A. A. Tarasenko V. Yu. Smolensky S. A. Egorova V. S. Smirnov A. M. Dashkevich T. N. Svetogor I. N. Glinskaya A. L. Skuranovich A. M. Milichkina A. M. Dronina E. O. Samoilovich I. V. Khamitova G. V. Semeiko T. V. Amvrosyeva N. P. Shmeleva L. V. Rubanik O. P. Esmanchik I. A. Karaban V. G. Drobyshevskaya G. V. Sadovnikova M. V. Shilovich E. A. Podushkina V. V. Kireichuk O. A. Petrova S. V. Bondarenko I. F. Salazhkova L. M. Tkach L. P. Shepelevich N. L. Autukhova V. M. Ivanov A. S. Babilo M. V. Navyshnaya N. N. Belyaev E. V. Zueva L. A. Volosar V. N. Verbov I. V. Likhachev T. O. Zagorskaya N. F. Morozova Z. R. Korobova A. V. Gubanova A. A. Totolian |
| author_facet |
A. Yu. Popova A. A. Tarasenko V. Yu. Smolensky S. A. Egorova V. S. Smirnov A. M. Dashkevich T. N. Svetogor I. N. Glinskaya A. L. Skuranovich A. M. Milichkina A. M. Dronina E. O. Samoilovich I. V. Khamitova G. V. Semeiko T. V. Amvrosyeva N. P. Shmeleva L. V. Rubanik O. P. Esmanchik I. A. Karaban V. G. Drobyshevskaya G. V. Sadovnikova M. V. Shilovich E. A. Podushkina V. V. Kireichuk O. A. Petrova S. V. Bondarenko I. F. Salazhkova L. M. Tkach L. P. Shepelevich N. L. Autukhova V. M. Ivanov A. S. Babilo M. V. Navyshnaya N. N. Belyaev E. V. Zueva L. A. Volosar V. N. Verbov I. V. Likhachev T. O. Zagorskaya N. F. Morozova Z. R. Korobova A. V. Gubanova A. A. Totolian |
| author_sort |
A. Yu. Popova |
| title |
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic |
| title_short |
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic |
| title_full |
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic |
| title_fullStr |
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic |
| title_full_unstemmed |
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic |
| title_sort |
herd immunity to sars-cov-2 among the population of the republic of belarus amid the covid-19 pandemic |
| publisher |
Sankt-Peterburg : NIIÈM imeni Pastera |
| publishDate |
2021 |
| url |
https://doaj.org/article/7a20d2a50a0d40778c1500b10a0c6507 |
| work_keys_str_mv |
AT ayupopova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT aatarasenko herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT vyusmolensky herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT saegorova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT vssmirnov herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT amdashkevich herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT tnsvetogor herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT inglinskaya herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT alskuranovich herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT ammilichkina herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT amdronina herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT eosamoilovich herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT ivkhamitova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT gvsemeiko herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT tvamvrosyeva herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT npshmeleva herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT lvrubanik herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT opesmanchik herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT iakaraban herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT vgdrobyshevskaya herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT gvsadovnikova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT mvshilovich herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT eapodushkina herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT vvkireichuk herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT oapetrova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT svbondarenko herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT ifsalazhkova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT lmtkach herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT lpshepelevich herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT nlautukhova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT vmivanov herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT asbabilo herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT mvnavyshnaya herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT nnbelyaev herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT evzueva herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT lavolosar herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT vnverbov herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT ivlikhachev herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT tozagorskaya herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT nfmorozova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT zrkorobova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT avgubanova herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic AT aatotolian herdimmunitytosarscov2amongthepopulationoftherepublicofbelarusamidthecovid19pandemic |
| _version_ |
1718417863645069312 |
| spelling |
oai:doaj.org-article:7a20d2a50a0d40778c1500b10a0c65072021-11-22T07:09:56ZHerd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic2220-76192313-739810.15789/2220-7619-HIT-1798https://doaj.org/article/7a20d2a50a0d40778c1500b10a0c65072021-11-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/1798https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Objective was to investigate the SARS-CoV-2 collective immunity status of the population of Belarus within the context of the COVID-19 pandemic. Materials and methods. The work was carried out according to the methodology for assessing SARS-CoV-2 population immunity, developed by Rospotrebnadzor Russia and the Ministry of Health of Belarus with the participation of the St. Petersburg Pasteur Institute, taking into account WHO recommendations. The Bioethics Committee of Belarus and the local ethics committee of the St. Petersburg Pasteur Institute approved the study. Selection of participants was carried out using a questionnaire method and online technology (internet, cloud server). Volunteers were randomized into seven age groups (years of age): 1–17; 18–29; 30–39; 40–49; 50–59; 60–69; and 70+. Regional randomization ensured proportional representation of volunteers from each region, and no more than 30 people were included from one enterprise. In accordance with manufacturer instructions, blood plasma samples were analyzed for: IgG antibodies (Abs) to the SARS-CoV-2 nucleocapsid (Nc) using a quantitative ELISA test system; and IgG Abs to the receptor binding domain (RBD) of the SARS-CoV-2 S (spike) surface glycoprotein using a qualitative ELISA test system. Statistical processing was carried out using Excel 2010 and other software. Statistical differences were designated as significant when p < 0.05, unless otherwise indicated. Results. The level of seroprevalence, in terms of Abs to Nc among the Belarusian population, was 38.4% (95% CI 37.6–45.4). The highest Ab levels were found among individuals in older age groups (50-70+ years old). The lowest were found in children 1–17 years old and in young people 18–39 years old The distribution of seroprevalence across Belarusian regions was relatively homogeneous, with the exception of the Minsk Region, where a statistically significant decrease in the indicator was noted. In terms of profession, the largest share of seropositive individuals was found among transportation workers; the smallest was found in business. The moderate COVID-19 incidence has not led to a dramatic increase in the number of contacts. The base reproduction number (R0) was 1.3. In the Republic of Belarus, there was a moderate level of asymptomatic COVID-19 among seropositive individuals (45.3% [95% CI 44.0–46.7]). This form of infection was observed most often among children aged 1–17 years old (65.0% [95% CI 61.3–68.6]). In parallel with seroprevalence assessment, SARS-CoV-2 vaccination was carried out. We used two vaccines: Gam-COVID-Vac (also known as Sputnik V, developed by Gamaleya National Center for Epidemiology and Microbiology, Russia); and BBIBP-CorV (Sinopharm, PRC). Vaccination against SARS-CoV-2 was accompanied by an increase in the level of anti-RBD Abs (95% [95% CI 94.7–96.7]). Taking into account the vaccination of a subset of the population with BBIBP-CorV, the overall herd immunity, inferred from the analyzed indicators (presence of anti-Nc or anti-RBD Abs), was 47.1% (95% CI 46.3–48.0). Conclusion. COVID-19 in Belarus was characterized by a moderately pronounced course of the epidemic process. The threshold level of herd immunity to SARS-CoV-2 has not yet been reached, as a result of which the conditions for progression of the epidemic remain.A. Yu. PopovaA. A. TarasenkoV. Yu. SmolenskyS. A. EgorovaV. S. SmirnovA. M. DashkevichT. N. SvetogorI. N. GlinskayaA. L. SkuranovichA. M. MilichkinaA. M. DroninaE. O. SamoilovichI. V. KhamitovaG. V. SemeikoT. V. AmvrosyevaN. P. ShmelevaL. V. RubanikO. P. EsmanchikI. A. KarabanV. G. DrobyshevskayaG. V. SadovnikovaM. V. ShilovichE. A. PodushkinaV. V. KireichukO. A. PetrovaS. V. BondarenkoI. F. SalazhkovaL. M. TkachL. P. ShepelevichN. L. AutukhovaV. M. IvanovA. S. BabiloM. V. NavyshnayaN. N. BelyaevE. V. ZuevaL. A. VolosarV. N. VerbovI. V. LikhachevT. O. ZagorskayaN. F. MorozovaZ. R. KorobovaA. V. GubanovaA. A. TotolianSankt-Peterburg : NIIÈM imeni Pasteraarticlecoronavirusessars-cov-2covid-19morbidityseroprevalenceasymptomatic courserepublic of belaruspopulationvaccinationanti-nucleocapsid antibodiesanti-rbd antibodiesgam-covid-vac vaccine (sputnik v)bbibp-corv vaccineInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 11, Iss 5, Pp 887-904 (2021) |